Welcome to our dedicated page for Trinity Capital news (Ticker: TRIN), a resource for investors and traders seeking the latest updates and insights on Trinity Capital stock.
Trinity Capital Inc. reports developments as an alternative asset manager and specialty lender focused on private credit for growth-oriented companies. Its recurring news includes quarterly financial results, net investment income, NAV movement, new commitments, funded investments, repayments, exits, and portfolio activity across Sponsor Finance, Equipment Finance, Tech Lending, Asset Based Lending, and Life Sciences.
Company updates also cover secured loans, equipment financings, warrant and equity investments, sponsored investment funds, SBIC-related activity, and growth-capital facilities for portfolio companies in technology, life sciences, medical technology, energy infrastructure, and other innovation-driven markets.
Trinity Capital Inc. (Nasdaq: TRIN), a provider of financial solutions to growth-stage companies, has announced a time change for its third quarter 2024 earnings conference call. The call will now take place at 8:00 a.m. PT (11:00 a.m. ET) on Wednesday, October 30, 2024, one hour earlier than previously scheduled. The company will release its Q3 2024 financial results before market open on the same day.
To participate in the call, investors can dial (800) 267-6316 or (203) 518-9783 internationally, referencing Conference ID: TRINQ324. A taped replay will be available until November 6, 2024, accessible by dialing (800) 839-1180 or (402) 220-0400. Additionally, a live webcast will be available on Trinity's investor relations website, with a replay accessible for 90 days following the call.
Trinity Capital Inc. (Nasdaq: TRIN), a provider of financial solutions to growth-stage companies, has announced the release date for its third quarter 2024 financial results. The results will be released before market open on Wednesday, October 30, 2024. Following the release, Trinity will host a conference call at 9:00 a.m. PT (12:00 p.m. ET) to discuss the results.
Investors can join the call by dialing (800) 267-6316 or (203) 518-9783 internationally, referencing Conference ID: TRINQ324. A taped replay will be available until November 6, 2024, accessible by dialing (800) 839-1180 or (402) 220-0400. Additionally, a live webcast of the call will be available on the company's investor relations website, with a replay accessible for 90 days following the conference.
Centivo, a healthcare company focused on making quality healthcare more affordable, has secured $75 million in equity and debt financing. The funding includes participation from new strategic investors Cone Health Ventures and MemorialCare Innovation Fund, as well as existing financial investors. This capital will help Centivo accelerate its mission of providing accessible and affordable healthcare to working families.
Centivo's three-part solution includes: (1) an advanced primary care centered model with Centivo Care, their in-house virtual primary care practice, (2) direct contracts with leading accountable care organizations in 18 major markets, and (3) a transparent, tech-enabled member engagement and plan administration platform. In 2023, Centivo's health plans achieved a 71% reduction in member out-of-pocket costs while typically saving employers 15% or more and increasing utilization of primary and specialty care.
Trinity Capital Inc. (Nasdaq: TRIN) has announced an expansion of its credit facility, increasing total commitments from $440 million to $510 million. This $70 million increase was achieved through the existing accordion feature and was provided by two new lenders, bringing the total number of participants in the diversified bank syndicate to 13. The credit facility, led by KeyBank N.A., now has an accordion feature allowing for maximum commitments of up to $690 million.
This expansion enhances Trinity's capacity as a leading provider of diversified financial solutions to growth-stage companies. The increased credit facility demonstrates Trinity's ability to attract new lenders and expand its financial resources, potentially enabling the company to support more growth-stage businesses with its financial solutions.
Trinity Capital Inc. (Nasdaq: TRIN) has declared a cash dividend of $0.51 per share for the third quarter of 2024. This marks the 19th consecutive quarter of a consistent or increased dividend. The dividend will be paid on October 15, 2024, to shareholders of record as of September 30, 2024.
Trinity Capital aims to distribute 90% to 100% of its taxable quarterly income through four quarterly dividends to qualify as a regulated investment company. The company may also pay additional supplemental dividends or carry over excess taxable income for future dividend payments. Dividends are paid from taxable earnings and may include a return of capital and/or capital gains.
Trinity Capital Inc. (NASDAQ: TRIN) has committed $30 million in growth capital to Slingshot Aerospace, a leader in AI-powered solutions for satellite tracking, space traffic coordination, and space modeling. Slingshot's platform provides a unified view of space for government and commercial operators, enhancing space situational awareness and operational efficiency.
The debt facility will enable Slingshot to scale operations and fund key growth initiatives. Ryan Thompson, Managing Director of Tech Lending at Trinity, emphasized the increasing importance of platforms like Slingshot as space becomes more crowded. Tim Solms, CEO of Slingshot Aerospace, stated that Trinity is an ideal partner for their rapidly scaling business.
Trinity Capital Inc. (NASDAQ: TRIN) has committed $20 million in growth capital to Kymeta, a leading flat-panel satellite antenna company based in Redmond, WA. Kymeta specializes in multi-network satellite communications, developing groundbreaking antennas that integrate with multiple satellite networks for unparalleled connectivity and reliability. The company's technology is based on metamaterial science, ensuring robust communications in challenging environments.
Bob D'Acquisto, Managing Director of Tech Lending at Trinity, expressed enthusiasm for supporting Kymeta's innovative technology in satellite communications. The new debt facility will enable Kymeta to scale operations and fund growth initiatives. Rick Bergman, President and CEO of Kymeta, welcomed Trinity's partnership as they aim to position themselves as the global leader in satellite communications on the move.
Trinity Capital Inc. (NASDAQ: TRIN) has committed $50 million in growth capital to LightForce, a company specializing in the world's first fully personalized 3D printed braces system. LightForce utilizes AI technology to generate accurate digital representations of patient anatomy and optimal teeth positions, improving treatment efficiency and aesthetics in orthodontics.
Ryan Kaeding, Managing Director of Life Sciences at Trinity, expressed excitement about partnering with LightForce and supporting their mission to empower orthodontists in creating unique bites and smiles for patients. Alfred Griffin III, CEO and co-founder of LightForce, stated that the financing from Trinity will help drive growth in their business and bring personalized braces solutions to orthodontists and patients.
Parafin, a leader in embedded finance, has secured a $93 million debt facility from Jefferies and Trinity Capital Inc., potentially expandable to $187 million. This follows a $125 million funding earlier this year from Silicon Valley Bank and Trinity Capital Inc. Parafin partners with major platforms like Amazon, Walmart, DoorDash, and Worldpay to offer financing to small businesses.
The company uses machine learning and over a billion data inputs to develop a robust underwriting model. This new funding reinforces Parafin's mission to solve small business financial services at scale by integrating their products into platforms that small businesses use for operations.
Trinity Capital Inc. (NASDAQ: TRIN) has committed $35 million in equipment financing to ApiJect Systems, Corp, a medical technology company focused on prefilled, single-dose injection devices. ApiJect, based in Stamford, CT, designs rapidly scalable, cost-efficient drug delivery systems for pharmaceutical companies. The financing will enable ApiJect to maximize the value of their hard assets, scale operations, and fund growth initiatives.
ApiJect aims to make injectable medicines and vaccines safer and more accessible worldwide. The company plans to expand its manufacturing capacity in the U.S., file for regulatory approval for its initial device in the coming months, and partner with more pharmaceutical companies interested in using their injection technology.